Cancer discovery news
Our researchers are making the discoveries that defeat cancer. Read the latest findings from our world-leading research.
Visit our main news hub to read about news on new funding, our fundraising activities and much more. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.
If you’re a journalist and want to find out more, you can contact our media relations team.
ASCO 2022: 'Practice-changing' radiotherapy technique can reduce swallowing problems for cancer patients
A new precision radiotherapy technique described as ‘practice changing’ has been shown to reduce long-term side effects, including swallowing problems, for patients with head and neck cancer following treatment.
ASCO 2022: Drug combination shows promise against cancer’s ‘death star’ protein
A drug combination targeting multiple mutant versions of cancer’s ‘death star’ protein has shown promise in a small, early-phase clinical trial for some patients with advanced lung, ovarian and thyroid cancer.
ASCO 2022: Screening of patients’ genomes for GPs to assess disease risk is ‘feasible’
Screening people’s genomes as part of routine primary care can spot genetic changes that may have important implications for health, a new study reports.
Cancer Revolution: Major exhibition opens at the Science Museum showcasing ICR research
A new, free exhibition chronicling how science is transforming cancer care opens at the Science Museum in London today – featuring discoveries led by researchers at The Institute of Cancer Research, London.
Scientists identify potential new drug combination for some skin cancers
A combination of two existing skin cancer drugs and a third experimental drug could lead to a new strategy for treating patients who do not respond to existing therapies, a new study in mice suggests.
New head and neck cancer radiotherapy technique could deliver more robust treatment plan in shorter time on MR Linac
New adaptive radiotherapy technique for head and neck cancer can deliver a more robust treatment plan in a shorter timeframe on MR Linac, compared with the current method used by most radiotherapy centres.
Scientists report link between male infertility and breast cancer in men
Infertile men may be twice as likely to develop breast cancer than those without fertility issues, according to new research published today.
Our research impact: breast cancer radiotherapy
To mark our outstanding success in REF2021, Gege Li spoke to two of our researchers here at the ICR who have played central roles in improving the use of radiotherapy in the treatment of breast cancer – transforming the lives of many thousands of patients.
Our research impact: prostate cancer radiotherapy
To mark our outstanding success in REF2021, Gege Li spoke to several of our researchers here at the ICR who have pioneered improved use of radiotherapy in the treatment of prostate cancer.
Our research impact: PARP inhibitors
To mark our outstanding success in REF2021, Alison Halliday spoke to several of our researchers here at the ICR who were instrumental in the development of PARP inhibitors, a type of targeted drug that’s been approved for use in breast, ovarian and prostate cancer.
AKT inhibitors: a new type of targeted cancer drug
To mark our outstanding success in REF2021, Alison Halliday shares the story of how our researchers revealed the 3D structure of the key cancer protein AKT, catalysing the discovery and development of at least 12 drugs now in clinical trials for a variety of cancers.
ICR rated second in UK among all higher education institutions in REF 2021 analysis
The Institute of Cancer Research, London, has rated second in REF 2021 – the Government’s evaluation of university research quality – among all higher education institutions in the UK that submitted at least two units of assessment.